Biogen (BIIB) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

BIIB is expected to report earnings to rise 8.72% to $3.99 per share on August 01

Q2'24

Est.

$3.99

Q1'24

Beat

by $0.24

Q4'23

Missed

by $0.23

Q3'23

Beat

by $0.37

Q2'23

Beat

by $0.24

The last earnings report on April 24 showed earnings per share of $3.67, beating the estimate of $3.43. With 1.14M shares outstanding, the current market capitalization sits at 31.34B.

View a ticker or compare two or three

Compare

BIIB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BIIB
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BIIB (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

Biotechnology

Address

225 Binney Street

Phone

+1 617 679-2000

Employees

7570

Web

https://www.biogen.com